https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Lassa. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-24171-j-phrp-2026-0226-be859bcd/ https://globalinfectiousdisease.com/research/articles/10-24171-j-phrp-2026-0226-be859bcd/ Mon, 31 Aug 2026 00:00:00 GMT The observed decline in diagnostic verification alongside sustained mortality suggests potential gaps in current monitoring frameworks. Recognizing environmental drivers and integrating cross-sectoral health approaches could strengthen future outbreak preparedness and response strategies. Lassa COVID-19 Climate and environment Surveillance One Health Ecological study https://globalinfectiousdisease.com/research/articles/10-1128-mbio-00880-26-65d0a25b/ https://globalinfectiousdisease.com/research/articles/10-1128-mbio-00880-26-65d0a25b/ Mon, 17 Aug 2026 00:00:00 GMT These viruses trigger severe human hemorrhagic illnesses with substantial mortality and scarce treatment alternatives. The observed cross-reactive antiviral properties indicate potential utility for developing broader therapeutic options. Lassa Hemorrhagic Fever Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1093-infdis-jiag229-ccbce199/ https://globalinfectiousdisease.com/research/articles/10-1093-infdis-jiag229-ccbce199/ Thu, 01 Jan 2026 00:00:00 GMT The abstract frames the outbreak as evidence that healthcare facilities in areas considered lower risk may still face nosocomial Lassa virus transmission in the context of human movement. It also emphasizes the operational relevance of rapid diagnostics, genomic analysis, and ecological investigation for outbreak response. Lassa Outbreak investigation Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2024-126479-f7b43214/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2024-126479-f7b43214/ Wed, 01 Jan 2025 00:00:00 GMT The abstract identifies substantial evidence gaps for diagnosis, management, prevention, and vaccine evaluation in pregnant women, neonates, and children. It highlights the need for research and vaccine trials that include these groups with safety monitoring and risk-mitigation procedures. Lassa Vaccination Surveillance Systematic review https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011390-dbb43ad8/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011390-dbb43ad8/ Mon, 22 Apr 2024 00:00:00 GMT The paper addresses a practical need for safer positive controls in disease surveillance testing when authentic positive material is limited or poses handling risks. It is relevant to diagnostics and assay validation workflows. Lassa Hemorrhagic Fever Rift Valley fever Ebola Marburg virus disease Crimean-Congo hemorrhagic fever One Health Surveillance Diagnostics Journal article